Novolex Retools to Manufacture Medical Protective Equipment
To aid healthcare professionals and first responders under increasing strain due to the COVID-19 crisis, Novolex has retooled its manufacturing capabilities and repurposed its supply chains to develop products to help protect them. After compressing what would typically be a six- to eight-month product development process into three weeks, Novolex is now ramping up its capabilities to produce up to 25,000 face shields and 100,000 medical isolation gowns per week.
“As international supply chains have stalled and the COVID-19 crisis escalated, we’ve seen a critical shortage in medical protective equipment in the U.S.,” said Phil Rozenski, Novolex’s vice president of Public Affairs. “When we found out about this need, it was a no-brainer. Our facilities are already uniquely equipped to produce food-grade products, so we are thrilled to be able to jump in and use our know-how and engineering expertise to make protective equipment that can really help those on the front lines.”